Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Trending on PharmExec

FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents

What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them

What Governance Resets Should Pharma Companies Take in Response to AI?

Conflict in Middle East Disrupts Pharma Drug Supplies: Report

Pharma Funding Roundup: Excalipoint Therapeutics Completes $68.7 Million Seed Finance Round, Crossbow Therapeutics Raises $77 Million in Series B Financing

Pharmaceutical Executive: March 2026 Interactive Digital Edition

Articles in this issue

Newsletter

Trending on PharmExec

FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents

What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them

What Governance Resets Should Pharma Companies Take in Response to AI?

Conflict in Middle East Disrupts Pharma Drug Supplies: Report

Pharma Funding Roundup: Excalipoint Therapeutics Completes $68.7 Million Seed Finance Round, Crossbow Therapeutics Raises $77 Million in Series B Financing